FDA's acting director of cell and gene therapies to leave position

June 30, 2026 10:47 AM EDT Cell/Gene TxFDA+ FDA's act­ing di­rec­tor of cell and gene ther­a­pies to leave po­si­tion Zachary Brennan Senior Editor Vi­jay Ku­mar is leav­ing his role as act­ing di­rec­tor of CBER’s Of­fice of Ther­a­peu­tic Prod­ucts and will soon con­sid­er op­tions both in­side and out­side the … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER